|
Rakesh Sharma
Designation:Project Associate-I
rakeshsharma9oct@gmail.com
Research Area:
Interested in identifying the potential of anti-cancer compounds targeting programmed cell death(PCD) pathways and their mechanism of PCD induction. Also studying the connection between ER stress, autophagy and immnuogenic cell death and their role in tumor immunotherapy
|
|
|
|
NISHAKUMARI SINGH
Designation:UGC-SRF
snishakumari13@gmail.com
Research Area:
My work focuses on investigating the potential of anti-cancer compounds to modulate autophagy in triple negative breast cancer cells. Specifically, it aims to understand the autophagy mediated cell death pathways, with a particular emphasis on studying organelle targeted autophagy using transmission electron microscopy.
|
|
|
|
Juhi Sharma
Designation:DST-Inspire
juhisharma71213@gmail.com
Research Area:
My research focuses on evaluating both natural and synthetic compounds for their anti-leishmanial effects, with an emphasis on metabolic pathways crucial for the survival of the parasite. I am exploring options for drug repurposing and studying how effective anti-leishmanial agents work, specifically examining their mechanisms of action.
|
|
|
|
Pragya Gupta
Designation:DBT-JRF
pragyagupta02709@gmail.com
Research Area:
My research work is centered on drug repurposing,investigating the signaling pathways and proteins involved in ER stress induced cell death in Triple Negative Breast Cancer (TNBC) cells, and exploring the potential therapeutic implications for cancer treatment.
|
|
|
|
Rohit Sahai
Designation:SRF
rohitsahai9@gmail.com
Research Area:
My research work explores the cell death mechanisms in cancer cells on treatment with potential anti-cancer compounds. My research interest includes understanding various cell signalling pathways for highlighting key factors that play pivotal role in the pathway, and targeting them for therapeutic response
|
|
|